BCL10 and diffuse large B-cell lymphoma: Xia et al. reported frequent mutations in BCL10 signaling mediators, which chronically activate the CBM signaling amplification complex, thereby contributing to an unfavorable outcome in activated B-cell-like diffuse large B-cell lymphoma (ABC-DLBCL) [62].